use of animal models to assess islet graft function
play

Use Of Animal Models To Assess Islet Graft Function Leif Jansson - PowerPoint PPT Presentation

Use Of Animal Models To Assess Islet Graft Function Leif Jansson Department of Medical Cell Biology Uppsala University Uppsala, Sweden Experimental Transplantation Samples of the isolated human islets can be implanted into normoglycemic


  1. Use Of Animal Models To Assess Islet Graft Function Leif Jansson Department of Medical Cell Biology Uppsala University Uppsala, Sweden

  2. Experimental Transplantation • Samples of the isolated human islets can be implanted into normoglycemic and/or hyperglycemic animals (nude mice or rats) - freshly isolated - after culture

  3. Experimental Transplantation • Allows for evaluation, at different times after implantation - short term (<3-4 days) - long term

  4. Animals VS Humans • Relevance of diabetes models • Absence of autoimmunity • Number of islets needed for cure • Implantation organs • Glucotoxicity • Lipotoxicity

  5. Implantation Site • Renal capsule • Liver (intraportally) • Spleen • Omental pouch • Other

  6. Experimental Transplantation SHORT TERM LONG TERM • Ability to induce • Cellular composition normoglycemia of graft • β -cells • Revascularization • Other cells • Reinnervation • Hormone release • Amyloid deposits

  7. Experimental Transplantation SHORT TERM LONG TERM • Ability to induce • Cellular composition normoglycemia of graft • β -cells • Revascularization; • Other cells • Reinnervation • Hormone release • Amyloid deposits

  8. Ability To Induce Normoglycemia • Number of islets needed? • When after implantation does normo- glycemia occur? • Dependent on implantation organ?

  9. Experimental Transplantation SHORT TERM LONG TERM • Ability to induce • Cellular composition normoglycemia of graft • β -cells • Revascularization; • Other cells • Reinnervation • Hormone release • Amyloid deposits

  10. Experimental Transplantation SHORT TERM LONG TERM • Ability to induce • Cellular composition normoglycemia of graft • β -cells • Revascularization; • Other cells • Reinnervation • Hormone release • Amyloid deposits

  11. Cellular Composition • Immunostaining of histological sections • Evaluation of number of different cell types and degree of fibrosis - Fibroblasts/myofibroblasts (stellate cells) - Macrophages/Dendritic cells - Nerve cells/Schwanns cells - Endothelial cells/pericytes

  12. Cellular Composition • Immunostaining of histological sections • Evaluation of number of different cell types and degree of fibrosis - Fibroblasts/myofibroblasts (stellate cells) - Macrophages/Dendritic cells - Nerve cells/Schwanns cells - Endothelial cells/pericytes

  13. Endothelial Cells • Vascular density, number of endothelial cells • (Blood perfusion) • pO 2 • Metabolism • Capillary blood pressure • Lymphatics • Vascular dysfunction

  14. Day 0-1 Post-Tx Apoptosis β -cells Necrosis O 2 , nutrients Insulin, metabolites Davalli et al, Diabetes 45:1161, 1996

  15. Revascularization • Revascularization initiated within 1-3 days and concluded within 7-14 days. Menger et al Diabetes 38(Suppl 1):199, 1989 • VASCULOGENESIS Formation from angioblasts • ANGIOGENESIS - Sprouting - Intussusceptive growth

  16. Vascular Density • Bandeiraea simplicifolia (BS-1) • Carlsson et al, JCEM 87:5418, 2002 • von Willebrand actor • Ulex lectin • CD31

  17. Decreased Growth Potential? Pregnant rats, gestational day 15 Johansson M et al, FASEB J, 19: A1713, 2005

  18. Improve Islet Revascularization • Stimulation of Islet Angiogenesis + - Angiostatic factors e.g. α 1- Pro-angiogenic factors, e.g VEGF, antitrypsin, endostatin, FGF, HGF, MMP-9 thrombospondins,TIMPs Vasir et al, Diabetologia 43:763, Lou et al, Diabetes 48:1773, 1999 2000 Tillmar and Welsh JOP 5:81, 2004 Vasir et al, Transplantation Mattsson et al, Pancreatology, in 71:924, 2001 press Bergers et al, Nat Cell Biol 2:737, 2000

  19. Vascular Organization Bonner-Weir and Orci, Diabetes 31:883, 1982

  20. In Vivo Microscopy In vivo microscopy with Evans Blue

  21. Endothelial Cells • Vascular density, number of endothelial cells • (Blood perfusion) • pO 2 • Metabolism • Capillary blood pressure • Lymphatics

  22. Blood Perfusion • In vivo microscopy with cross correlation • Laser-Doppler flowmetry • Hydrogen gas clearance • All these techniques can be used on the same graft

  23. Endothelial Cells • Vascular density, number of endothelial cells • (Blood perfusion) • pO 2 • Metabolism • Capillary blood pressure • Lymphatics

  24. Microdialysis Diameter 200 µm

  25. Anaerobic Metabolism One-month-old islet graft non-diabetic diabetic Carlsson et al, Am J Physiol Carlsson et al, Surgery 132:487, 284:E499, 2003 2002

  26. Endothelial Cells • Vascular density, number of endothelial cells • (Blood perfusion) • pO 2 • Metabolism • All these parameters can be studied in the same graft

  27. Experimental Transplantation SHORT TERM LONG TERM LONG TERM • Ability to induce • Cellular Cellular composition composition • normoglycemia of graft graft of • Surviving β -cells • Revascularization Revascularization; ; • • Other cells • Reinnervation Reinnervation • • Hormone release • Amyloid Amyloid deposits deposits •

  28. Studies Of Hormone Release • Ability to induce normoglycemia • Removal of graft and in vitro perifusion (excludes livers) • Perfusion of graft-bearing organ (graft vasculature) • The latter two allows for studies also of glucagon and somatostatin

  29. Kidney Perfusion

  30. Insulin Release Human Islets • Biphasic release from islets in normoglycemic recipients • Impaired release in hyperglycemic recipients • Jansson et al; J Clin Invest 96:721, 1995

  31. Retrieved Islets from Liver One-month-old islet grafts Control Islets Retrieved Islets Retrieved islet visualized by Neutral Red Mattsson et al, Diabetes 53: 948, 2004

  32. Intrahepatic Graft • Revascularization occurs from hepatic artery, and only to a minor extent from portal vein Andersson et al, Diabetes 38(Suppl 1): 192, 1989

  33. Liver Vascular Anatomy Botini et al, Liver Int 25:861, 2005

  34. Intrahepatic Grafts • Morphological studies to asses the degree of fragmentation • New in vivo imaging techiques; -MRI -Optiplex

  35. Experimental Transplantation SHORT TERM LONG TERM • Ability to induce • Cellular composition normoglycemia of graft • Surviving β -cells • Revascularization; • Other cells • Reinnervation • Hormone release • Amyloid deposits

  36. Islet Amyloid Westermark et al; Metabolism 48:448, 1999

  37. Amyloid Deposits • Amyloid occurs in 73% of human islet grafts within 2 weeks after implantation into nude mice ( Westermark et al; Metabolism 48:448, 1999 ) • Initially amyloid is formed intracellularly ( Westermark et al; Upsala J med Sci 108:193, 2003 )

  38. Conclusion • Experimental islet transplantation of human islets offers unique possibilities to assess graft function in both the short and long term perspective

  39. Acknowledgements • Arne Andersson • Göran Mattsson • Birgitta Bodin • Astrid Nordin • Per-Ola Carlsson • Johan Olerud • Åsa Johansson • Richard Olsson • Magnus Johansson • Fredrik Palm • Cecilia Johnsson • Lisbeth Sagulin • Caroline Kampf • Eva Törnelius • Örjan Källskog • Joey Lau

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend